-
1
-
-
0015914428
-
Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
-
Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77-9.
-
(1973)
Science
, vol.179
, pp. 77-79
-
-
Brazeau, P.1
Vale, W.2
Burgus, R.3
Ling, N.4
Butcher, M.5
Rivier, J.6
-
2
-
-
0032780823
-
Somatostatin and its receptor family
-
DOI 10.1006/frne.1999.0183
-
Patel YC. Somatostatin and its receptor family. Frontiers in Neuroendocrinology 1999;20:157-98. (Pubitemid 29362641)
-
(1999)
Frontiers in Neuroendocrinology
, vol.20
, Issue.3
, pp. 157-198
-
-
Patel, Y.C.1
-
3
-
-
0023574423
-
Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system
-
Reubi JC, Lang W, Maurer R, Koper JW, Lamberts SWJ. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res 1987;47:5758-64. (Pubitemid 18046777)
-
(1987)
Cancer Research
, vol.47
, Issue.21
, pp. 5758-5764
-
-
Reubi, J.C.1
Lang, W.2
Maurer, R.3
Koper, J.W.4
Lamberts, S.W.J.5
-
4
-
-
0024117485
-
The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors
-
Lamberts SW. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocrine Reviews 1988;9:417-36.
-
(1988)
Endocrine Reviews
, vol.9
, pp. 417-436
-
-
Lamberts, S.W.1
-
5
-
-
0042854927
-
Peptide receptors as molecular targets for cancer diagnosis and therapy
-
DOI 10.1210/er.2002-0007
-
Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 2003;24:389-427. (Pubitemid 37056239)
-
(2003)
Endocrine Reviews
, vol.24
, Issue.4
, pp. 389-427
-
-
Reubi, J.C.1
-
6
-
-
27644516836
-
The present and future role of (111)In pentetreotide in the PET era
-
Rambaldi PF, Cuccurullo V, Briganti V, Mansi L. The present and future role of (111)In pentetreotide in the PET era. Q J Nucl Med Mol Imaging 2005;49;3:225-35.
-
(2005)
Q J Nucl Med Mol Imaging
, vol.49
, Issue.3
, pp. 225-235
-
-
Rambaldi, P.F.1
Cuccurullo, V.2
Briganti, V.3
Mansi, L.4
-
7
-
-
4444323262
-
Neuroendocrine tumors-somatostatin receptor expression and somatostatin analog treatment
-
Janson ET, Oberg K. Neuroendocrine tumors-somatostatin receptor expression and somatostatin analog treatment. Cancer Chemother Biol Response Modif 2003;21:535-46.
-
(2003)
Cancer Chemother Biol Response Modif
, vol.21
, pp. 535-546
-
-
Janson, E.T.1
Oberg, K.2
-
8
-
-
6044266281
-
Somatostatin and other peptide receptors as tools for tumor diagnosis and treatment
-
Reubi JC. Somatostatin and other peptide receptors as tools for tumor diagnosis and treatment. Neuroendocrinology 2004;80:51-6.
-
(2004)
Neuroendocrinology
, vol.80
, pp. 51-56
-
-
Reubi, J.C.1
-
9
-
-
0034924612
-
Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
-
DOI 10.1007/s002590100541
-
Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor sstl-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 2001;28:836-46. (Pubitemid 32662546)
-
(2001)
European Journal of Nuclear Medicine
, vol.28
, Issue.7
, pp. 836-846
-
-
Reubi, J.C.1
Waser, B.2
Schaer, J.-C.3
Laissue, J.A.4
-
10
-
-
0031201409
-
Somatostatin receptor subtype expression in human tissues: A prediction for diagnosis and treatment of cancer
-
Virgolini I, Pangeri T, Bischof C, Smith-Jones P, PeckRadosavljevic M. Somatostatin receptor subtype expression in human tissues: a prediction for diagnosis and treatment of cancer. Eur J Clin Invest 1997;27:645-7.
-
(1997)
Eur J Clin Invest
, vol.27
, pp. 645-647
-
-
Virgolini, I.1
Pangeri, T.2
Bischof, C.3
Smith-Jones, P.4
PeckRadosavljevic, M.5
-
11
-
-
0035460593
-
Immunological imaging using tagged octreotide
-
Cascini GL, Cuccurullo V, Rambaldi PF, Mansi L. Immunological imaging using tagged octreotide. Minerva Endocrinol 2001;26;3:129-33.
-
(2001)
Minerva Endocrinol
, vol.26
, Issue.3
, pp. 129-133
-
-
Cascini, G.L.1
Cuccurullo, V.2
Rambaldi, P.F.3
Mansi, L.4
-
13
-
-
5444228828
-
From the magic bullet to an effective therapy: The peptide experience
-
DOI 10.1007/s00259-004-1661-3
-
Mansi L. From the magic bullet to an effective therapy: the peptide experience. Eur J Nucl Med Mol Imaging 2004;31:1393-8. (Pubitemid 39361935)
-
(2004)
European Journal of Nuclear Medicine and Molecular Imaging
, vol.31
, Issue.10
, pp. 1393-1398
-
-
Mansi, L.1
-
14
-
-
4544356397
-
Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors
-
Bombardiert E, Seregni E, Villano C, Chiti A, Bajetta E. Related Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors. Q J Nucl Med Mol Imaging. 2004;48:150-63. (Pubitemid 39248302)
-
(2004)
Quarterly Journal of Nuclear Medicine and Molecular Imaging
, vol.48
, Issue.2
, pp. 150-163
-
-
Bombardieri, E.1
Seregni, E.2
Villano, C.3
Chiti, A.4
Bajetta, E.5
-
15
-
-
0034945583
-
New trends in peptide receptor radioligands
-
Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li SR et al. New trends in peptide receptor radioligands. Q J Nucl Med 2001;45:153-9. (Pubitemid 32640389)
-
(2001)
Quarterly Journal of Nuclear Medicine
, vol.45
, Issue.2
, pp. 153-159
-
-
Virgolini, I.1
Traub, T.2
Novotny, C.3
Leimer, M.4
Fuger, B.5
Li, S.R.6
Patri, P.7
Pangerl, T.8
Angelberger, P.9
Raderer, M.10
Andreae, F.11
Kurtaran, A.12
Dudczak, R.13
-
16
-
-
17844393439
-
Radiolabelling DOTApeptides with 68Ga
-
Breeman WA, de Jong M, de Blois E, Bernard BF, Konijnenberg M, Krenning EP. Radiolabelling DOTApeptides with 68Ga. Eur J Nucl Med Mol Imaging 2005;32:478-85.
-
(2005)
Eur J Nucl Med Mol Imaging
, vol.32
, pp. 478-485
-
-
Breeman, W.A.1
De Jong, M.2
De Blois, E.3
Bernard, B.F.4
Konijnenberg, M.5
Krenning, E.P.6
-
17
-
-
0036226273
-
Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings
-
de Jong M, Valkema R, Jamar F. Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings. Semin Nucl Med 2002;32:133-40.
-
(2002)
Semin Nucl Med
, vol.32
, pp. 133-140
-
-
De Jong, M.1
Valkema, R.2
Jamar, F.3
-
18
-
-
14844366257
-
A pragmatic perspective on molecular targeted radionuclide therapy
-
Larson SM, Krenning EP. A pragmatic perspective on molecular targeted radionuclide therapy. J Nucl Med 2005;46(Suppl 1):1S-3S.
-
(2005)
J Nucl Med
, vol.46
, Issue.SUPPL. 1
-
-
Larson, S.M.1
Krenning, E.P.2
-
19
-
-
59749083610
-
Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro
-
Lesche S, Lehmann D, Nagel F, Schmid HA, Schulz S. Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro. J Clin Endocrinol Metab 2009;94:654-61.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 654-661
-
-
Lesche, S.1
Lehmann, D.2
Nagel, F.3
Schmid, H.A.4
Schulz, S.5
-
20
-
-
45749096710
-
Effects of somatostatin analog SOM230 on cell proliferation apoptosis and catechnolamine levels in cultured pheochromocytoma cells
-
DOI 10.1677/JME-08-0012
-
Pasquali D, Rossi V, Conzo G, Pannone G, Bufo P, De Bellis A et al. Effects of somatostatin analog SOM230 on cell proliferation, apoptosis, and catecholamine levels in cultured pheochromocytoma cells. J Mol Endocrinol 2008;40:263-71. (Pubitemid 351865034)
-
(2008)
Journal of Molecular Endocrinology
, vol.40
, Issue.5-6
, pp. 263-271
-
-
Pasquali, D.1
Rossi, V.2
Conzo, G.3
Pannone, G.4
Bufo, P.5
De Bellis, A.6
Renzullo, A.7
Bellastella, G.8
Colao, A.9
Vallone, G.10
Bellastella, A.11
Sinisi, A.A.12
-
21
-
-
0037907532
-
Concomitant expression of several peptide receptors in neuroendocrine tumours: Molecular basis for in vivo multireceptor tumour targeting
-
Reubi JC, Waser B. Concomitant expression of several peptide receptors in neuroendocrine tumors: molecular basis for in vivo multireceptor tumour targeting. Eur J Nucl Med Mol Imaging 2003;30:781-93. (Pubitemid 36612963)
-
(2003)
European Journal of Nuclear Medicine and Molecular Imaging
, vol.30
, Issue.5
, pp. 781-793
-
-
Reubi, J.C.1
Waser, B.2
-
22
-
-
79952110645
-
A review on the clinical uses of SPECT/CT
-
Mariani G, Bruselli L, Kuwert T, Kim EE, Flotats A, Israel O et al. A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging 2010;37:1959-85.
-
(2010)
Eur J Nucl Med Mol Imaging
, vol.37
, pp. 1959-1985
-
-
Mariani, G.1
Bruselli, L.2
Kuwert, T.3
Kim, E.E.4
Flotats, A.5
Israel, O.6
-
23
-
-
77952506362
-
Imaging of neuroendocrine tumors with gamma-emitting radiopharmaceuticals
-
Bombardiert E, Coliva A, Maccauro M, Seregni E, Orunesu E, Chiti A et al. Imaging of neuroendocrine tumors with gamma-emitting radiopharmaceuticals. Q J Nucl Med Mol Imaging 2010;54:3-15.
-
(2010)
Q J Nucl Med Mol Imaging
, vol.54
, pp. 3-15
-
-
Bombardiert, E.1
Coliva, A.2
Maccauro, M.3
Seregni, E.4
Orunesu, E.5
Chiti, A.6
-
24
-
-
67349213883
-
Clinical indications for Gallium-68 positron emission tomography imaging
-
Khan MU, Khan S, El-Refaie S, Win Z, Rubello D, Al-Nahhas A. Clinical indications for Gallium-68 positron emission tomography imaging. Eur J Surg Oncol 2009;35:561-7.
-
(2009)
Eur J Surg Oncol
, vol.35
, pp. 561-567
-
-
Khan, M.U.1
Khan, S.2
El-Refaie, S.3
Win, Z.4
Rubello, D.5
Al-Nahhas, A.6
-
25
-
-
77956639140
-
Somatostatin analogues: Treatment of pituitary and neuroendocrine tumors
-
Colao A, Faggiano A, Pivonello R. Somatostatin analogues: treatment of pituitary and neuroendocrine tumors. Prog Brain Res 2010;182:281-94.
-
(2010)
Prog Brain Res
, vol.182
, pp. 281-294
-
-
Colao, A.1
Faggiano, A.2
Pivonello, R.3
-
26
-
-
0029929673
-
Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: In vitro identification
-
Reubi JC, Waser B, Laissue JA, Gebbers J-O. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification. Cancer Res 1996;56:1922-31. (Pubitemid 26118233)
-
(1996)
Cancer Research
, vol.56
, Issue.8
, pp. 1922-1931
-
-
Reubi, J.C.1
Waser, B.2
Laissue, J.A.3
Gebbers, J.-O.4
-
27
-
-
33744992729
-
Potential indications for somatostatin analogues: Immune system and limphoproliferative disorders
-
Ferone D, Resmini E, Boschetti M, Arvigo M, Albanese V, Ceresola et al. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders. J Endocrinol Invest 2005;28(11 Suppl International):111-7.
-
(2005)
J Endocrinol Invest
, vol.28
, Issue.11 SUPPL. INTERNATIONAL
, pp. 111-117
-
-
Ferone, D.1
Resmini, E.2
Boschetti, M.3
Arvigo, M.4
Albanese, V.5
Ceresola6
-
30
-
-
77956186159
-
Our experience in thymic hyperplasia using 67Ga-citrate, 111In-pentetreotide and 201T1-chloride
-
Rambaldi PF, Cuccurullo V, Cascini GL, Mansi L. Our experience in thymic hyperplasia using 67Ga-citrate, 111In-pentetreotide and 201T1-chloride. Eur J Nucl Med Mol Imaging 2010;37:1616.
-
(2010)
Eur J Nucl Med Mol Imaging
, vol.37
, pp. 1616
-
-
Rambaldi, P.F.1
Cuccurullo, V.2
Cascini, G.L.3
Mansi, L.4
-
31
-
-
77952510480
-
The non tumour uptake of (111)In-octreotide creates new clinical indications in benign diseases, but also in oncology
-
Cascini GL, Cuccurullo V, Mansi L. The non tumour uptake of (111)In-octreotide creates new clinical indications in benign diseases, but also in oncology. Q J Nucl Med Mol Imaging 2010;54:24-36.
-
(2010)
Q J Nucl Med Mol Imaging
, vol.54
, pp. 24-36
-
-
Cascini, G.L.1
Cuccurullo, V.2
Mansi, L.3
-
32
-
-
78649341427
-
Diagnostics of neuroendocrine tumors
-
Hodolic M, Fettich J, Banti E, Chondrogiannis S, AlNahhas A, Rubello D. Diagnostics of neuroendocrine tumors. In Vivo 2010;24:771-4.
-
(2010)
In Vivo
, vol.24
, pp. 771-774
-
-
Hodolic, M.1
Fettich, J.2
Banti, E.3
Chondrogiannis, S.4
AlNahhas, A.5
Rubello, D.6
-
33
-
-
0031789246
-
Intraoperative detection of lung cancer by octreotide labeled to Indium- 111
-
DOI 10.1002/(SICI)1098-2388(199812)15:4<220::AID-SSU6>3.0.CO;2-T
-
Pastore V, Di Lieto E, Mansi L, Rambaldi PF, Santini M, Mancusi R. Intraoperative detection of lung cancer by octreotide labeled to Indium-111. Sem Surg Onc 1998;15:220-2. (Pubitemid 28511997)
-
(1998)
Seminars in Surgical Oncology
, vol.15
, Issue.4
, pp. 220-222
-
-
Pastore, V.1
Di, L.E.2
Mansi, L.3
Rambaldi, P.F.4
Santini, M.5
Mancusi, R.6
-
34
-
-
0035751511
-
Role of radio-guided surgery with 111In-octreotide in the treatment of thoracic neoplasms
-
Santini M, Rambaldi PF, Di Lieto E, Cuccurullo V, Vicidomini G, Di Crescenzo VG et al. Role of radio-guided surgery with 111In-octreotide in the treatment of thoracic neoplasms. Minerva Endocrinol 2001;26:285-8.
-
(2001)
Minerva Endocrinol
, vol.26
, pp. 285-288
-
-
Santini, M.1
Rambaldi, P.F.2
Di Lieto, E.3
Cuccurullo, V.4
Vicidomini, G.5
Di Crescenzo, V.G.6
-
35
-
-
0031418445
-
Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors
-
Briganti V, Sestini R, Orlando C, Bernini G, La Cava G, Tamburini A et al. Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors. Clin Cancer Res 1997;3(12 Pt 1):2385-91. (Pubitemid 28133159)
-
(1997)
Clinical Cancer Research
, vol.3
, Issue.12 I
, pp. 2385-2391
-
-
Briganti, V.1
Sestini, R.2
Orlando, C.3
Bernini, G.4
La, C.G.5
Tamburini, A.6
Raggi, C.C.7
Serio, M.8
Maggi, M.9
-
36
-
-
0031452035
-
111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid
-
DOI 10.1530/eje.0.1370688
-
Mansi L, Rambaldi PF, Panza N, Esposito D, Esposito V, Pastore V. Diagnosis and radioguided surgery with 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid. Eur J Endocrinol 1997;137:688-90. (Pubitemid 28005266)
-
(1997)
European Journal of Endocrinology
, vol.137
, Issue.6
, pp. 688-690
-
-
Mansi, L.1
Rambaldi, P.F.2
Panza, N.3
Esposito, D.4
Esposito, V.5
Pastore, V.6
-
37
-
-
0035137671
-
Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis
-
Lebtahi R, Crestani B, Belmatoug N, Daou D, Genin R, Dombret MC et al. Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis. J Nucl Med 2001;42:21-6. (Pubitemid 32104772)
-
(2001)
Journal of Nuclear Medicine
, vol.42
, Issue.1
, pp. 21-26
-
-
Lebtahi, R.1
Crestani, B.2
Belmatoug, N.3
Daou, D.4
Genin, R.5
Dombret, M.C.6
Palazzo, E.7
Faraggi, M.8
Aubier, M.9
Le, G.D.10
-
38
-
-
0028116419
-
Somatostatin receptor imaging. The presence of somatostatin receptors in rheumatoid arthritis
-
Vanhagen PM, Markusse HM, Lamberts SW, Kwekkeboom DJ, Reubi JC, Krenning EP. Somatostatin receptor imaging. The presence of somatostatin receptors in rheumatoid arthritis. Arthritis Rheum 1994;37:1521-7.
-
(1994)
Arthritis Rheum
, vol.37
, pp. 1521-1527
-
-
Vanhagen, P.M.1
Markusse, H.M.2
Lamberts, S.W.3
Kwekkeboom, D.J.4
Reubi, J.C.5
Krenning, E.P.6
-
39
-
-
0033623561
-
111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis
-
Weinmann P, Crestani B, Tazi A, Genereau T, Mal H, Aubier M et al. 111In-pentetreotide scintigraphy in patients with Langerhans' cell histiocytosis. J Nucl Med 2000;41:1808-12.
-
(2000)
J Nucl Med
, vol.41
, pp. 1808-1812
-
-
Weinmann, P.1
Crestani, B.2
Tazi, A.3
Genereau, T.4
Mal, H.5
Aubier, M.6
-
40
-
-
0031715791
-
Somatostatin receptor imaging in patients with sarcoidosis
-
Kwekkeboom DJ, Krenning EP, Siang Kho G, Breeman WAP, Van Hagen PM. Somatostatin receptor imaging in patients with sarcoidosis. Eur J Nucl Med 1998;25:1284-92.
-
(1998)
Eur J Nucl Med
, vol.25
, pp. 1284-1292
-
-
Kwekkeboom, D.J.1
Krenning, E.P.2
Siang Kho, G.3
Breeman, W.A.P.4
Van Hagen, P.M.5
-
41
-
-
33749048089
-
111In-octreotide in idiopathic pulmonary fibrosis
-
Lebtahi R, Moreau S, Marchand-Adam S, Debray MP, Brauner M, Soler P et al. Increased uptake of 111Inoctreotide in idiopathic pulmonary fibrosis. J Nucl Med 2006;47:1281-7. (Pubitemid 47544880)
-
(2006)
Journal of Nuclear Medicine
, vol.47
, Issue.8
, pp. 1281-1287
-
-
Lebtahi, R.1
Moreau, S.2
Marchand-Adam, S.3
Debray, M.-P.4
Brauner, M.5
Soler, P.6
Marchal, J.7
Raguin, O.8
Gruaz-Guyon, A.9
Reubi, J.-C.10
Le, G.D.11
Crestani, B.12
-
42
-
-
77349104615
-
Graves' ophthalmopathy
-
Bahn RS. Graves' ophthalmopathy. N Engl J Med 2010;362:726-38.
-
(2010)
N Engl J Med
, vol.362
, pp. 726-738
-
-
Bahn, R.S.1
-
43
-
-
77955375528
-
Pathogenesis of Graves' orbitopathy: A 2010 update
-
Smith TJ. Pathogenesis of Graves' orbitopathy: a 2010 update. J Endocrinol Invest 2010;33:414-21.
-
(2010)
J Endocrinol Invest
, vol.33
, pp. 414-421
-
-
Smith, T.J.1
-
44
-
-
0033679581
-
Somatostatin-receptor scintigraphy in Graves' disease: Reproducibility and variance of orbital activity
-
Förster GJ, Krummenauer F, Nickel O, Kahaly GJ. Somatostatin- receptor scintigraphy in Graves' disease: reproducibility and variance of orbital activity. Cancer Biother Radiopharm 2000;15:517-25.
-
(2000)
Cancer Biother Radiopharm
, vol.15
, pp. 517-525
-
-
Förster, G.J.1
Krummenauer, F.2
Nickel, O.3
Kahaly, G.J.4
-
45
-
-
0028955466
-
Indium-111-pentetreotide scintigraphy in Graves' ophthalmopathy
-
Kahaly G, Diaz M, Hahn K, Beyer J, Bockisch A. Indium-111-pentetreotide scintigraphy in Graves' ophthalmopathy. J Nucl Med 1995;30:550-4.
-
(1995)
J Nucl Med
, vol.30
, pp. 550-554
-
-
Kahaly, G.1
Diaz, M.2
Hahn, K.3
Beyer, J.4
Bockisch, A.5
-
46
-
-
0033855356
-
Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from graves' ophthalmopathy
-
Pasquali D, Vassallo P, Esposito D, Bonavolontà G, Bellastella A, Sinisi AA. Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy. J Mol Endocrinol 2000;25:63-71. (Pubitemid 30617075)
-
(2000)
Journal of Molecular Endocrinology
, vol.25
, Issue.1
, pp. 63-71
-
-
Pasquali, D.1
Vassallo, P.2
Esposito, D.3
Bonavolonta, G.4
Bellastella, A.5
Sinisi, A.A.6
-
47
-
-
0028670368
-
[111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: A parameter for disease activity?
-
Postema PT, Krenning EP, Wijngaarde R, Kooy PP, Oei HY, van den Bosch WA et al. [111In-DTPA-D-Phe1] octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity? J Clin Endocrinol Metab 1994;79:1845-51.
-
(1994)
J Clin Endocrinol Metab
, vol.79
, pp. 1845-1851
-
-
Postema, P.T.1
Krenning, E.P.2
Wijngaarde, R.3
Kooy, P.P.4
Oei, H.Y.5
Van Den Bosch, W.A.6
-
48
-
-
2642618579
-
Indium-111-pentetreotide in Graves' disease
-
Kahaly G, Görges R, Diaz M, Hommel G, Bockisch A. Indium-111-pentetreotide in Graves' disease. J Nucl Med 1998;39:533-6. (Pubitemid 28136858)
-
(1998)
Journal of Nuclear Medicine
, vol.39
, Issue.3
, pp. 533-536
-
-
Kahaly, G.1
Gorges, R.2
Diaz, M.3
Hommel, G.4
Bockisch, A.5
-
49
-
-
77952490362
-
Indio-111 Octreotide nelle malattie tiroidee autoimmuni e nella oftalmopatia attiva
-
Milano, 9-11 dicembre
-
Mansi L, Bizzarro A, De Bellis A, Panza N, Rambaldi PF, Di Martino S et al. Indio-111 Octreotide nelle malattie tiroidee autoimmuni e nella oftalmopatia attiva. Atti XI Giornate Italiane della Tiroide. Milano, 9-11 dicembre 1993. p. 123.
-
(1993)
Atti XI Giornate Italiane Della Tiroide
, pp. 123
-
-
Mansi, L.1
Bizzarro, A.2
De Bellis, A.3
Panza, N.4
Rambaldi, P.F.5
Di Martino, S.6
-
50
-
-
0029103270
-
E. Indium-111 octreotide in Graves' disease and in the evaluation of active exophthalmos
-
Mansi L, Rambaldi PF, Bizzarro A, Panza N, Di Martino S, De Bellis A et al. E. Indium-111 octreotide in Graves' disease and in the evaluation of active exophthalmos. Q J Nucl Med 1995;39:105-10.
-
(1995)
Q J Nucl Med
, vol.39
, pp. 105-110
-
-
Mansi, L.1
Rambaldi, P.F.2
Bizzarro, A.3
Panza, N.4
Di Martino, S.5
De Bellis, A.6
-
51
-
-
0029421747
-
111In-octreotide in the evaluation of autoimmune thyroid diseases
-
Mansi L, Rambaldi PF, Bizzarro A, Panza N, Del Vecchio E. 111In-octreotide in the evaluation of autoimmune thyroid diseases. Q J Nucl Med 1995;39:127-30.
-
(1995)
Q J Nucl Med
, vol.39
, pp. 127-130
-
-
Mansi, L.1
Rambaldi, P.F.2
Bizzarro, A.3
Panza, N.4
Del Vecchio, E.5
-
52
-
-
0005416301
-
Octreotidescintigraphy is a disease-activity parameter in Graves' ophthalmopathy
-
(Oxf)
-
Gerding MN, van der Zant FM, van Royen EA, Koornneef L, Krenning EP, Wiersinga WM et al. Octreotidescintigraphy is a disease-activity parameter in Graves' ophthalmopathy. Clin Endocrinol (Oxf) 1999;50:373-9.
-
(1999)
Clin Endocrinol
, vol.50
, pp. 373-379
-
-
Gerding, M.N.1
Van Der Zant, F.M.2
Van Royen, E.A.3
Koornneef, L.4
Krenning, E.P.5
Wiersinga, W.M.6
-
53
-
-
0030934783
-
111In-octreotide
-
Moncayo R, Baldissera I, Decristoforo C, Kendler D, Donnemiller E. Evaluation of immunological mechanisms mediating thyroid-associated ophthalmopathy by radionuclide imaging using the somatostatin analog 111In-octreotide. Thyroid 1997;7:21-9. (Pubitemid 27132891)
-
(1997)
Thyroid
, vol.7
, Issue.1
, pp. 21-29
-
-
Moncayo, R.1
Baldissera, I.2
Decristoforo, C.3
Kendler, D.4
Donnemiller, E.5
-
54
-
-
0028900990
-
Somatostatin receptors in the orbits
-
Durak I, Durak H, Ergin M, Yürekli Y, Kaynak S. Somatostatin receptors in the orbits. Clin Nucl Med 1995;20:237-42.
-
(1995)
Clin Nucl Med
, vol.20
, pp. 237-242
-
-
Durak, I.1
Durak, H.2
Ergin, M.3
Yürekli, Y.4
Kaynak, S.5
-
55
-
-
0029012202
-
Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease
-
Krassas GE, Dumas A, Pontikides N, Kaltsas T. Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease. Clin Endocrinol 1995;42:571-80.
-
(1995)
Clin Endocrinol
, vol.42
, pp. 571-580
-
-
Krassas, G.E.1
Dumas, A.2
Pontikides, N.3
Kaltsas, T.4
-
56
-
-
0032919656
-
Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy
-
DOI 10.1007/s002590050419
-
Nocaudie M, Bailliez A, Itti E, Bauters C, Wemeau JL, Marchandise X. Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy. Eur J Nucl Med 1999;26:511-7. (Pubitemid 29209790)
-
(1999)
European Journal of Nuclear Medicine
, vol.26
, Issue.5
, pp. 511-517
-
-
Nocaudie, M.1
Bailliez, A.2
Itti, E.3
Bauters, C.4
Wemeau, J.-L.5
Marchandise, X.6
-
57
-
-
33748601201
-
Clinical approach of cushing syndrome resulting from ACTH-producing metastatic neuroendocrine tumor
-
DOI 10.1097/01.ten.0000188475.05398.09, PII 0001961620051100000016
-
Teves D.A. Clinical approach of cushing syndrome resulting from ACTH-producing metastatic neuroendocrine tumor. Endocrinologist 2005;15:401-4. (Pubitemid 44378705)
-
(2005)
Endocrinologist
, vol.15
, Issue.6
, pp. 401-404
-
-
Teves, D.A.1
-
58
-
-
0024344152
-
Cushing syndrome due to primary pigmented nodular adrenocortical disease: Findings at CT and MR imaging
-
Doppman JL, Travis WD, Nieman L, Miller DL, Chrousos GP, Gomez MT et al. Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. Radiology 1989;172:415-20. (Pubitemid 19184880)
-
(1989)
Radiology
, vol.172
, Issue.2
, pp. 415-420
-
-
Doppman, J.L.1
Travis, W.D.2
Nieman, L.3
Miller, D.L.4
Chrousos, G.P.5
Gomez, M.T.6
Cutler Jr., G.B.7
Loriaux, D.L.8
Norton, J.A.9
-
59
-
-
23844508434
-
Cushing's syndrome due to ectopic corticotropin secretion: Twenty years' experience at the National Institutes of Health
-
DOI 10.1210/jc.2004-2527
-
Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab 2005;90:4955-62. (Pubitemid 41159396)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.8
, pp. 4955-4962
-
-
Ilias, I.1
Torpy, D.J.2
Pacak, K.3
Mullen, N.4
Wesley, R.A.5
Nieman, L.K.6
-
60
-
-
29244462313
-
Evaluation and treatment of Cushing's syndrome
-
DOI 10.1016/j.amjmed.2005.01.059, PII S0002934305001609
-
Nieman LK, Ilias I. Evaluation and treatment of Cushing's syndrome. Am J Med 2005;118:1340-6. (Pubitemid 41832323)
-
(2005)
American Journal of Medicine
, vol.118
, Issue.12
, pp. 1340-1346
-
-
Nieman, L.K.1
Ilias, I.2
-
61
-
-
0344513889
-
Octreoscan in patients with bronchial carcinoid tumours
-
DOI 10.1046/j.1365-2265.2003.01931.x
-
Granberg D, Sundin A, Janson ET, Oberg K, Skogseid B, Westlin JE. Octreoscan in patients with bronchial carcinoid tumors. Clin Endocrinol (Oxf) 2003;59:793-9. (Pubitemid 37491586)
-
(2003)
Clinical Endocrinology
, vol.59
, Issue.6
, pp. 793-799
-
-
Granberg, D.1
Sundin, A.2
Janson, E.T.3
Oberg, K.4
Skogseid, B.5
Westlin, J.-E.6
-
62
-
-
28244446189
-
Experience with somatostatin receptor scintigraphy in the management of pulmonary carcinoid tumors
-
Yellin A, Zwas ST, Rozenman J, Simansky DA, Goshen E. Experience with somatostatin receptor scintigraphy in the management of pulmonary carcinoid tumors. Isr Med Assoc J 2005;7:712-6.
-
(2005)
Isr Med Assoc J
, vol.7
, pp. 712-716
-
-
Yellin, A.1
Zwas, S.T.2
Rozenman, J.3
Simansky, D.A.4
Goshen, E.5
-
63
-
-
77749270829
-
Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors
-
Zemskova MS, Gundabolu B, Sinaii N, Chen CC, Carrasquillo JA, Whatley M et al. Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab 2010;95:1207-19.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 1207-1219
-
-
Zemskova, M.S.1
Gundabolu, B.2
Sinaii, N.3
Chen, C.C.4
Carrasquillo, J.A.5
Whatley, M.6
-
64
-
-
77956383370
-
Paraneoplastic syndromes: An approach to diagnosis and treatment
-
Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc 2010;85:838-54.
-
(2010)
Mayo Clin Proc
, vol.85
, pp. 838-854
-
-
Pelosof, L.C.1
Gerber, D.E.2
-
65
-
-
0032798419
-
Non-islet cell tumour hypoglycaemia
-
DOI 10.1046/j.1365-2265.1999.00789.x
-
Teale JD. Non-islet cell tumour hypoglycaemia. Clin Endocrinol (Oxf) 1999;51:147. (Pubitemid 29378895)
-
(1999)
Clinical Endocrinology
, vol.51
, Issue.2
, pp. 147
-
-
Teale, J.D.1
-
66
-
-
19744366733
-
Octreotide in insulinoma patients: Efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies
-
DOI 10.1530/eje.1.01901
-
Vezzosi D, Bennet A, Rochaix P, Courbon F, Selves J, Pradere B et al. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. Eur J Endocrinol 2005;152:757-67. (Pubitemid 40744545)
-
(2005)
European Journal of Endocrinology
, vol.152
, Issue.5
, pp. 757-767
-
-
Vezzosi, D.1
Bennet, A.2
Rochaix, P.3
Courbon, F.4
Selves, J.5
Pradere, B.6
Buscail, L.7
Susini, C.8
Caron, P.9
-
68
-
-
0029786926
-
Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels
-
Reubi JC, Schaer JC, Laissue JA, Waser B. Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels. Metabolism 1996;45(8 Suppl 1):39-41.
-
(1996)
Metabolism
, vol.45
, Issue.8 SUPPL. 1
, pp. 39-41
-
-
Reubi, J.C.1
Schaer, J.C.2
Laissue, J.A.3
Waser, B.4
-
69
-
-
14944360740
-
Octreotide therapy for tumor-induced osteomalacia
-
Seufert J, Ebert K, Müller J, Eulert J, Hendrich C, Werner E et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 2001;345:1883-8. (Pubitemid 33716563)
-
(2001)
New England Journal of Medicine
, vol.345
, Issue.26
, pp. 1883-1888
-
-
Seufert, J.1
Ebert, K.2
Muller, J.3
Eulert, J.4
Hendrich, C.5
Werner, E.6
Schutze, N.7
Schulz, G.8
Kenn, W.9
Richtmann, H.10
Palitzsch, K.-D.11
Jakob, F.12
-
70
-
-
0037198438
-
Octreotide for tumor-induced osteomalacia
-
Paglia F, Dionisi S, Minisola S. Octreotide for tumor-induced osteomalacia. N Engl J Med 2002;346:1748-9.
-
(2002)
N Engl J Med
, vol.346
, pp. 1748-1749
-
-
Paglia, F.1
Dionisi, S.2
Minisola, S.3
-
71
-
-
70449087310
-
Somatostatin receptor expression in an epitheloid hemangioma causing oncogenic osteomalacia
-
Mussig k, Ozer Oksu M, Pfannenberg C, Adam P, Zustinj, Beckert S et al. Somatostatin receptor expression in an epitheloid hemangioma causing oncogenic osteomalacia. J Clin Endocrinol Metab 2009;94:4123-4.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 4123-4124
-
-
Mussig, K.1
Ozer Oksu, M.2
Pfannenberg, C.3
Adam, P.4
Zustinj5
Beckert, S.6
|